K094030 is an FDA 510(k) clearance for the FORE-SIGHT ABSOLUTE CEREBRAL AND SOMATIC OXIMETER, MC 2000 SERIES, MODELS MC2.... Classified as Oximeter, Tissue Saturation (product code MUD), Class II - Special Controls.
Submitted by Cas Medical Systems, Inc. (Branford, US). The FDA issued a Cleared decision on December 23, 2010 after a review of 358 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2700 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
View all Cas Medical Systems, Inc. devices
NCT00849940
Terminated
Interventional
Validation of Brain Oxygenation Monitor on Pediatric Patients
Validation of the CAS Medical System, Inc. FORE-SIGHT Near-Infrared Spectroscopy (NIRS) Monitor in Pediatric Subjects for Viscerosomatic Applications
| Condition studied |
Cardiac Catheterization |
| Study design |
Single group |
| Eligibility |
All sexes
|
| Principal investigator |
David B MacLeod, FCRA |
| Sponsor |
Duke University
|
Started 2009-02-01
→
Primary completion 2014-11-01
Primary outcome
Accuracy of NIRS Sensor to Estimate Flank Tissue Oxygen Saturation
Secondary outcome
Correlation Between Somatic StO2 and Cerebral SctO2 Oxygen Saturation
View full study on ClinicalTrials.gov